BioHiTech Enters Into Agreement to Distribute Altapure High-Level Disinfectant Technology That Can Effectively Kill Bacteria, Fungus, C.Difficile Spores, and Viruses Such as Coronavirus 2 (SARS-CoV-2)

CHESTNUT RIDGE, N.Y., June 2, 2020 /PRNewswire/ -- BioHiTech Global, Inc. ("BioHiTech" or the "Company") (NASDAQ: BHTG), a technology and services company that provides cost-effective and sustainable environmental management solutions, today announced that it has entered into an agreement with Altapure, LLC ("Altapure"), a technology developer and manufacturer of ultrasonic based disinfecting products, to distribute its patented line of environmentally-friendly, high-level disinfecting products.

"This partnership with Altapure to distribute their product line of effective and environmentally friendly high-level disinfection technologies presents an important evolution at BioHiTech, as it demonstrates our dedication toward executing on the vision of being a trusted provider of the most effective green technology solutions available -- whether developed in-house or identified through our relationships -- to healthcare, hospitality, restaurant, grocery, government and cruise industry customers across the globe," said Frank E. Celli, CEO of BioHiTech. "We believe that Altapure's technology can help achieve high-level disinfection for our customers in areas like infirmaries, guest or patient rooms, and small common areas in a post-COVID-19 environment. Altapure's technology may also have the ability to be used for disinfecting personal protective equipment so that it may be reused safely, potentially offering substantial savings in PPE expenditures. We look forward to working together with the team at Altapure to begin to pursue opportunities to help our customers thrive with a new eye towards safety as our country and the rest of the world begins to reopen for business."

Altapure is an innovative technology and manufacturing company dedicated to providing ultrasonic based products for high-level disinfection. Altapure's newest product, the AP-4™, was launched in 2017, and is an enhanced, automated and touchless high-level disinfection sub-micron aerosol system providing a safe process and rapid kill of spores, viruses, and vegetative bacteria, such as but not limited to: COVID-19, Acinetobacter baumanii, Pseudomonas aeruginosa, VRE, MRSA, Bacillus atrophaeus, Geobacillus stearothermophilus, Polio virus, C. auris and Clostridium difficile (C. difficile). 

Extensive research and development alongside Harris Corporation, formerly ITT Exelis, a top-tier global aerospace, defense, and information solutions company, resulted in the creation of a very unique and patented aerosol generation technology that when coupled with the liquid agent Altacare^®, a reagent grade peracetic acid solution, yields rapid and unparalleled results for high level disinfection. Altapure is committed to providing its customers with the highest quality products and processes in the marketplace that are safe to use and are environmentally friendly. All of Altapure's products are engineered, manufactured, and assembled in the U.S.

"We are excited to establish this relationship with BioHiTech to expand the distribution reach of our state-of-the-art high-level disinfection technologies," said Carl L. Ricciardi, co-founder and CEO of Altapure. "BioHiTech has established itself as a leading technology innovator in the environmental industry, with a customer base that we see as a natural fit for our products. We look forward to a long and mutually beneficial relationship with their team as we work to help businesses safely return to more normal operations."

Additional Links:
https://altapure.com/wp-content/uploads/2020/04/Efficacy-of-a-multi-purpose-high-level-disinfection-cabinet-against-Candida-auris-and-other-health-care-associated-pathogen.pdf

https://altapure.com/wp-content/uploads/2016/12/AJIC-article-Altapure.pdf

https://altapure.com/technology/test-results-efficacy/

About BioHiTech Global
BioHiTech Global, Inc. (NASDAQ: BHTG), is changing the way we think about managing waste.  Our cost-effective technology solutions include the patented processing of municipal solid waste into a valuable renewable fuel, biological disposal of food waste on-site, and proprietary real-time data analytics tools to reduce food waste generation. Our unique solutions enable businesses and municipalities of all sizes to lower disposal costs while having a positive impact on the environment.  When used individually or in combination, our solutions lower the carbon footprint associated with waste transportation and can reduce or virtually eliminate landfill usage. For more information, please visit www.biohitech.com.

Forward Looking Statements
Statements in this press release contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. Without limiting the foregoing, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "explore," "evaluate," "intend," "may," "might," "plan," "potential," "predict," "project," "seek," "should," or "will," or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company's control. These statements are also based on many assumptions and estimates and are not guarantees of future performance. These statements are estimates, based on information available to management as of the date of this release, and are subject to further changes. These statements may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of BioHiTech Global, Inc. to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. BioHiTech Global, Inc. assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future in these forward-looking statements, even if new information becomes available in the future. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission ("SEC"). There may be other factors not mentioned above or included in the BioHiTech's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. BioHiTech Global, Inc. assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.

Company Contact:
BioHiTech Global, Inc.
Richard Galterio
Executive Vice President
Direct: 845.367.0603
rgalterio@biohitech.com
www.biohitech.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/biohitech-enters-into-agreement-to-distribute-altapure-high-level-disinfectant-technology-that-can-effectively-kill-bacteria-fungus-cdifficile-spores-and-viruses-such-as-coronavirus-2-sars-cov-2-301069015.html

SOURCE BioHiTech Global, Inc.